Market Cap
445922368.00
SIGA
SIGA Technologies, Inc.
Exchange: nyse
Multiples
- P/E: 5.20
- P/BV: 2.63
- P/TBV: 2.28
Description:
SIGA Technologies, Inc. (ticker: SIGA) is a biopharmaceutical company listed on the New York Stock Exchange (NYSE). The company focuses on the research, development, and commercialization of novel therapeutics for the treatment of serious infectious diseases and bioterror threats. SIGA has gained recognition for its product TPOXX (tecovirimat), which was approved by the U.S. Food and Drug Administration (FDA) for the treatment of smallpox. This approval marked a significant milestone for the company as it positioned itself as a key player in biodefense and infectious disease treatments.
Data:
Yields:
Earnings Yield
-1.075251082015
Return on Capital
0.605070245451
CAGR (net income)
11.84%
CAGR Length
3.75
Dividend Rate
